Form D · Biotechnology
GULF CHRONIC CARE INC.
Draper, UT · CIK 0001762400
Offering snapshot reported Mar 8, 2019 · SEC filing
- Reported sold
- $60K Indefinite offering
- Investors reported
- 4 Form D · investor count
- Minimum accepted
- $170K Reported outside-investor minimum
- First sale
- Dec 3, 2018 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Mar 8, 2019 | Initial | $60,000 | No comparison | 4 | SEC filing |
| Jan 29, 2019 | Initial | $60,000 | No comparison | 4 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-334383
Source: Form D, filed Mar 8, 2019. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Brannelly John | Executive |
| Rockwell Max | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
12465 S. Fort Street, Suite 240
Draper, UT, 84020
Draper, UT, 84020